Примери за използване на Qtc prolongation на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
QTc prolongation.
Grade 4 QTc prolongation.
QTc prolongation(see section 4.4).
Congenital or acquired QTc prolongation.
QT/QTc prolongation.
Хората също превеждат
Torsades de pointes a rare: QTc prolongation a, oedema.
QTc prolongation and Torsades de Pointes.
No significant effect on QTc prolongation was observed for SANCUSO.
QTc prolongation has been observed in patients treated with ceritinib.
Eight percent of patients had a dose reduction due to QTc prolongation.
Bradycardia QTc prolongation(see section 4.4).
The risk of ventricular arrhythmias,possibly associated with QTc prolongation, must be considered.
Bradycardia QTc prolongation(see section 4.4).
Frequent monitoring for adverse reactions and toxicity related to methadone,including QTc prolongation, is recommended.
ECG QTc prolongation appears to be dose-dependent.
The results show that the QT/QTc prolongation is clearly dose dependent.
QTc prolongation has been observed with the use of efavirenz(see sections 4.5 and 5.1).
For patients who develop QTc prolongation, see sections 4.2, 4.8 and 5.2.
QTc prolongation is very closely correlated with the major delamanid metabolite DM-6705.
Assay sensitivity was confirmed by significant QTc prolongation of the positive control, moxifloxacin.
Management of QTc prolongation may require specific monitoring measures(see section 4.4).
The PRAC noted the recurrent concomitant use of delamanid with bedaquiline in patients experiencing QTc prolongation.
NUEDEXTA has the potential to cause QTc prolongation and hence torsades de pointes-type ventricular tachycardia.
Of the 2,182 patients who received dasatinib in Phase II/ III clinical trials,18 had QTc prolongation reported as an adverse event.
There is a risk of QTc prolongation and Vibativ should be used with caution in patients taking medicinal products known to prolong the QT interval.
Additional analysis suggests that the risk of QTc prolongation does not increase over time(see section 4.2).
Worst-case QTc prolongation of> 60 millisecond(msec) was observed in 3% of dabrafenib-treated subjects(one> 500 msec in the integrated safety population).
It must also not be used in pregnant or breastfeeding women orpatients who have QTc prolongation(disruption of the electrical activity of the heart).
An increased frequency of QTc prolongation was noted in midostaurin-treated patients(see section 4.8), however, a mechanistic explanation for this observation was not found.
If you are at risk for a certain type of abnormal heart rhythm(e.g. torsade de pointes or QTc prolongation), your heart will be monitored continuously.